Started as India’s first independent product development company, Rubicon Research has developed and scaled up several drug products. In 2016, we successfully scaled up our 100th product and have gone on to expand our development expertise with a commercial focus, leading to multiple product approvals and launches. We leverage our proprietary technologies and specialized formulation development skills to provide innovative solutions to complex delivery challenges. Rubicon Research has launched 40 SKUs, with over 1 billion extended units sold in the US in 2019. Additionally, we have 20 approvals and launches (across oral solids and ophthalmic formulations) in the pipeline for 2020.
Product: Buprenorphine Hydrochloride
Strength: 2 mg (Base), 8 mg (Base)
Formulation: Tablet
Product: Diclofenac Potassium
Strength: 50 mg
Formulation: Tablet
Product: Nefopam Hydrochloride
Strength: 30 mg
Formulation: Tablet
Product: Tramadol Hydrochloride
Strength: 50 mg
Formulation: Tablet
Product: Pantoprazole Sodium
Strength: 20 mg (Base), 40 mg (Base)
Formulation: Delayed Release Tablet
Product: Rabeprazole Sodium
Strength: 20 mg
Formulation: Delayed Release Tablet
Product: Bisoprolol Fumarate
Strength: 5 mg, 10 mg
Formulation: Tablet
Product: Carvedilol
Strength: 3.125 mg, 6.25 mg, 12.5 mg, 25 mg
Formulation: Tablet
Product: Metoprolol Tartrate
Strength: 25 mg, 37.5 mg, 50 mg, 75 mg, 100 mg
Formulation: Tablet
Product: Midodrine Hydrochloride
Strength: 2.5 mg, 5 mg, 10 mg
Formulation: Tablet
Product: Sildenafil Citrate
Strength: 20 mg (Base)
Formulation: Tablet
Product: Sildenafil Citrate
Strength: 25 mg (Base), 50 mg (Base), 100 mg (Base)
Formulation: Tablet
Product: Amantadine Hydrochloride
Strength: 100 mg
Formulation: Capsule
Product: Amantadine Hydrochloride
Strength: 200 mg
Formulation: Tablet
Product: Clonazepam
Strength: 0.5 mg, 1 mg, 2 mg
Formulation: Tablet
Product: Desvenlafaxine Succinate
Strength: 50 mg (Base), 100 mg (Base)
Formulation: Extended Release Tablet
Product: Gabapentin
Strength: 600 mg, 800 mg
Formulation: Tablet
Product: Lamotrigine
Strength: 25 mg, 100 mg, 150 mg, 200 mg
Formulation: Tablet
Product: Lamotrigine
Strength: 100 mg, 200 mg
Formulation: Extended Release Tablet
Product: Oxcarbazepine
Strength: 150 mg, 300 mg, 600 mg
Formulation: Tablet
Product: Rizatriptan Benzoate
Strength: 5 mg (Base), 10 mg (Base)
Formulation: Orally Disintegrating Tablet
Product: Sapropterin Dihydrochloride
Strength: 100 mg
Formulation: Tablet
Product: Baclofen
Strength: 5 mg, 10 mg, 20 mg
Formulation: Tablet
Product: Cyclobenzaprine Hydrochloride
Strength: 5 mg, 7.5 mg, 10 mg
Formulation: Tablet
Product: Tizanidine Hydrochloride
Strength: 2 mg (Base), 4 mg (Base), 6 mg (Base)
Formulation: Capsule
Product: Nicotine Polacrilex
Strength: 2 mg, 4 mg
Formulation: Lozenge
Product: Buspirone Hydrochloride
Strength: 5 mg, 10 mg, 15 mg
Formulation: Tablet
Product: Loratadine
Strength: 10 mg
Formulation: Orally Disintegrating Tablet
Product: Ciprofloxacin Hydrochloride
Strength: 0.3% (Base)
Formulation: Solution/Drops
Product: Diclofenac Sodium
Strength: 0.1%
Formulation: Solution/Drops
Product: Dorzolamide Hydrochloride
Strength: 2% (Base)
Formulation: Solution/Drops
Product: Dorzolamide Hydrochloride and Timolol Maleate
Strength: 2% (Base), 0.5% (Base)
Formulation: Solution/Drops
Product: Levofloxacin
Strength: 0.5% (Base)
Formulation: Solution/Drops